Subtotal Gastrectomy with D2 Lymphadenectomy

2020 ◽  
pp. 41-51
Author(s):  
Tommy Ivanics ◽  
Rupen Shah
Keyword(s):  
Subtotal Gastrectomy ◽  
D2 Lymphadenectomy

scholarly journals Robotic distal subtotal gastrectomy with D2 lymphadenectomy for advanced gastric cancer: a case report and technical description

2020 ◽  
Vol 2 (1) ◽  
pp. 18-21
Author(s):  
Francesco Giovanardi
Keyword(s):  
Gastric Cancer ◽  
Case Report ◽  
Three Dimensional ◽  
Subtotal Gastrectomy ◽  
Gastric Surgery ◽  
Robotic Systems ◽  
D2 Lymphadenectomy ◽  
Tips And Tricks ◽  
Technical Details ◽  
Three Dimensional Vision

Robotic systems have revolutionized the way we perform minimally invasive surgery and has facilitated the evolution of traditional laparoscopic gastric surgery. Surgeons have several advantages that can overcome some of the well-known limits of laparoscopy: three-dimensional vision, articulated instruments, the absence of tremors. These can give greater dexterity and precision in dissection and suturing movements that are key elements when performing complex and gentle reconstruction to restore digestive continuity. The present case shows the technical details and tips and tricks of a robotic surgical approach for a subtotal gastrectomy.

scholarly journals Robotic Sentinel Lymph Node Procedure After Endoscopic Submucosal Dissection of High Risk Early Gastric Cancer: A Case Report

2020 ◽  
pp. 1-3
Author(s):  
Alexander B.J. Borgstein ◽  
Alexander B.J. Borgstein ◽  
WJ Eshuis ◽  
SS Gisbertz ◽  
MI van Berge Henegouwen
Keyword(s):  
Gastric Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Early Gastric Cancer ◽  
Subtotal Gastrectomy ◽  
Lymph Node Involvement ◽  
D2 Lymphadenectomy ◽  
Robot Assisted ◽  
Sentinel Lymph Node Procedure ◽  
Additional Gastrectomy

Endoscopic resection (ER) is the treatment of choice for early gastric cancer (T1) without lymph node involvement. An additional gastrectomy with D2 lymphadenectomy is recommended if ER is considered as non-curative. Here, we present a case of a robot-assisted sentinel lymph node procedure performed with the use of duel-tracer, including ICG fluorescence and technetium-99, after a non-curative ESD for an early gastric tumor. Five “hot” lymph nodes were resected, one of which was positive for metastasis. A subtotal gastrectomy with D2 lymphadenectomy was performed additionally during the same procedure. This case presentation indicates the feasibility of a robot-assisted sentinel lymph node procedure in early gastric cancer.

Full Robotic Subtotal Gastrectomy with Extended (D2) Lymphadenectomy

Videoscopy ◽  
2012 ◽  
Vol 22 (2) ◽  
Author(s):  
Annibale D'Annibale ◽  
Vito Pende ◽  
Graziano Pernazza ◽  
Igor Monsellato ◽  
Giovanni Alfano ◽  
...  
Keyword(s):  
Subtotal Gastrectomy ◽  
D2 Lymphadenectomy

The prognostic significance of Cerb-B2 determination in gastric cancer.

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. e14713-e14713
Author(s):  
Antonio CALDEIRA Fradique
Keyword(s):  
Gastric Cancer ◽  
Lymph Node ◽  
Lymph Node Metastases ◽  
Statistical Significance ◽  
Prognostic Significance ◽  
Subtotal Gastrectomy ◽  
D2 Lymphadenectomy ◽  
Tumor Aggressiveness ◽  
Resectable Gastric Cancer ◽  
Node Metastases

e14713 Background: The Cerb-B2/HER2 marker, is a glycoprotein encoded by the ERBB2 oncogene, belongs to the family of epidermal growth factor receptors (EGFR), which has based its application on tests of new therapeutic modalities (target therapy). Apart from this interest has been invoked its value as a marker of tumor aggressiveness, due to his role as a regulator of cell proliferation and migration and consequent invasiveness and metastization. However, the results as to the meaning prognosis of this molecular marker are controversial and with variations depending on the geographical zone. Results: From a total of 50 pts. with advanced resectable gastric cancer that underwent surgery with D2 lymphadenectomy, 38 pts. had a total gastrectomy, and 12 pts. had subtotal gastrectomy. A mean of 35.7 lymph nodes/pt were resected at surgery. In 68% of pts. positive lymph node metastases were present. Tumor HER2-neu overexpression was observed in 16 pts (32%), several other parameters of tumor aggressiveness were also present, without any statistical significance or relevance. Methods: To determine if the Cerb-B2 played a prognostic role in gastric cancer, a total of 50 pts. with advanced resectable gastric cancer, were submitted to gastrectomy with D2 lymphadenectomy. In all cases assessment for tumor HER2-neu overexpression was performed using immunohistochemistry (IHC). FISH was used as a confirmation method in tumors with 2+ expression by IHC. A correlation was made between the tumor HER2-neu expression and the following parameters: tumor location, size, histological type, depth of invasion, lymph node metastases and clinical staging. Results: From a total of 50 pts. with advanced resectable gastric cancer that underwent surgery with D2 lymphadenectomy, 38 pts. had a total gastrectomy, and 12 pts. had subtotal gastrectomy. A mean of 35.7 lymph nodes/pt were resected at surgery. In 68% of pts. positive lymph node metastases were present.Tumor HER2-neu overexpression was observed in 16 pts (32%), several other parameters of tumor aggressiveness were also present, without any statistical significance or relevance. Conclusions: The determination of Cerb-B2 / HER2 expression has not shown prognostic significance in this study.

Sign in / Sign up

Export Citation Format

Share Document